Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, November 10, 2021
Anavasi Diagnostics announces it has been awarded $14.9 million from the NIH Rapid Acceleration of Diagnostics initiative.
read more
Tuesday, November 18, 2014
New Oncology announced today that it has entered into a collaboration with the National Cancer Centre Singapore (NCCS). Under this agreement, New Oncology will apply its proprietary [2]diagnostic platform ‘NEO’ that enables physicians to select ...
read more
Monday, December 11, 2017
Thermo Fisher Scientific's Ion Torrent Oncomine Myeloid Research Assay interrogates DNA mutations, RNA fusion transcripts and gene expression levels.
read more
RSSL is to launch several new services to the biopharmaceutical sector, covering all aspects of the EMA regulatory guidelines for safety, quality and efficacy of biopharmaceuticals. Services will be GMP compliant where appropriate.
read more
Monday, February 04, 2019
ValGenesis announced a New Jersey-based leading contract manufacturer of pharmaceutical drugs has chosen ValGenesis's 100% paperless VLMS to manage its validation lifecycle process.
read more
Wednesday, November 11, 2015
The Biotechnology Industry Organization (BIO) and BioNJ have commended Governor Chris Christie for signing critical legislation to create a pathway for the substitution of interchangeable biologic medicines.
read more
The FDA has sent a warning letter to Tris Pharma after investigators found the company had failed to properly investigate batch failures and establish quality control procedures.
read more
Laureate Biopharma is pleased to announce its successful collaboration with Dyax Corp. for process development and cGMP production of a new treatment candidate for hereditary angioedema (HAE). The drug candidate, known as DX-2930, is a fully human ...
read more
Friday, December 13, 2013
Thomas Feinberg, PhD, Catalent Pharma Solutions’ Director of Development and Analytical Solutions, is to present at the forthcoming “Suitability and Compatibility for Packaging and Delivery Systems
read more
TTP and New England Biolabs (NEB) announce that they have established a non-exclusive partnership to offer services to molecular diagnostic technology developers.
read more
Thursday, February 08, 2018
Bluebee and New England Biolabs have partnered to provide a secure and convenient data processing solution for NEB's NEBNext Direct target enrichment technology.
read more
Monday, November 23, 2020
ABEC announced New England Biolabs has selected ABEC to expand production capacity at their manufacturing facilities in Ipswich and Rowley, MA.
read more
Crown Bioscience announced the appointment of Laurie Heilmann as President of CrownBio Global Life Science Product and Diagnostic Solutions.
read more
Cannovation Clinical Research Partners, a pioneering Cannabis-Based Clinical Research Organization for Drug and Product Development, is proudly announcing its official launch, marking a significant milestone in pharmaceutical and biotech innovation.
read more
Wednesday, December 23, 2020
The GCSA has launched with a commitment to increase clinical research and trial capacity and quality in the UK as well as Globally.
read more